Joseph P McConnell

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review
    Carolina A Garza
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 82:159-65. 2007
  2. doi request reprint Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
    Michael H Davidson
    Preventive Cardiology Center, Pritzker School of Medicine, University of Chicago, 515 North State Street, Chicago, IL 60610, USA
    Am J Cardiol 101:51F-57F. 2008
  3. ncbi request reprint Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods
    Joseph P McConnell
    Department of Laboratory, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Clin Chem Lab Med 40:56-9. 2002
  4. ncbi request reprint Lipoprotein-associated phospholipase A2
    Joseph P McConnell
    Department of Laboratory Medicine and Pathology, The Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Clin Lab Med 26:679-97, vii. 2006
  5. pmc Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome
    Joerg Herrmann
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Eur Heart J 30:2930-8. 2009
  6. pmc Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
    Dallit Mannheim
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Stroke 39:1448-55. 2008
  7. pmc Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men
    Manivannan Srinivasan
    Division of Endocrinology, Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 95:1617-25. 2010
  8. ncbi request reprint Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo Clinic, Mary Brigh 4 523, First ST SW, Rochester, MN 55905, USA
    Circulation 115:2715-21. 2007
  9. pmc Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients
    Eugenia Raichlin
    William J von Liebig Transplant Center, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Transplantation 85:963-8. 2008
  10. pmc Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community
    Yariv Gerber
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, United States
    Atherosclerosis 203:593-8. 2009

Detail Information

Publications51

  1. ncbi request reprint Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review
    Carolina A Garza
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 82:159-65. 2007
    ..To estimate the association between plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels and cardiovascular disease (CVD)...
  2. doi request reprint Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
    Michael H Davidson
    Preventive Cardiology Center, Pritzker School of Medicine, University of Chicago, 515 North State Street, Chicago, IL 60610, USA
    Am J Cardiol 101:51F-57F. 2008
    ..However, at this time Lp-PLA(2) cannot be recommended as a target of therapy...
  3. ncbi request reprint Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods
    Joseph P McConnell
    Department of Laboratory, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Clin Chem Lab Med 40:56-9. 2002
    ..0001), was independent of age differences as assessed by multiple regression analysis. The observed gender differences have important implications for the establishment of cut-off points for cardiovascular risk stratification...
  4. ncbi request reprint Lipoprotein-associated phospholipase A2
    Joseph P McConnell
    Department of Laboratory Medicine and Pathology, The Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Clin Lab Med 26:679-97, vii. 2006
    ..Recent evidence that suggests Lp-PLA2's potential usefulness as a therapeutic target also is reviewed...
  5. pmc Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome
    Joerg Herrmann
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Eur Heart J 30:2930-8. 2009
    ..The aim was to test the hypothesis that carotid artery plaque expression of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) predicts cardiac events...
  6. pmc Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
    Dallit Mannheim
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Stroke 39:1448-55. 2008
    ..Therefore, this study was performed to test the hypothesis that Lp-PLA(2) expression is higher in symptomatic than in asymptomatic carotid plaques of patients undergoing carotid endarterectomy...
  7. pmc Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men
    Manivannan Srinivasan
    Division of Endocrinology, Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 95:1617-25. 2010
    ..Although age-related declines in dehydroepiandrosterone sulfate (DHEAS) and testosterone are associated with cardiovascular risk, it remains to be determined whether replacement of these hormones improves cardiovascular risk factors...
  8. ncbi request reprint Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo Clinic, Mary Brigh 4 523, First ST SW, Rochester, MN 55905, USA
    Circulation 115:2715-21. 2007
    ..Inflammation also is associated with coronary atherosclerosis. We tested the hypothesis that local coronary production of Lp-PLA2 is enhanced in patients with early coronary atherosclerosis and associated with local endothelial function...
  9. pmc Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients
    Eugenia Raichlin
    William J von Liebig Transplant Center, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Transplantation 85:963-8. 2008
    ..We evaluated the association between Lp-PLA2, cardiac allograft vasculopathy (CAV) assessed by 3D intravascular ultrasound, and incidence of cardiac adverse events in heart transplant recipients...
  10. pmc Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community
    Yariv Gerber
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, United States
    Atherosclerosis 203:593-8. 2009
    ..We evaluated the association of Lp-PLA2 with mortality in subjects with HF and assessed its incremental value for risk discrimination over established risk factors and biomarkers...
  11. doi request reprint Association between the paraoxonase-1 192Q>R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease
    Shahar Lavi
    Division of Cardiovascular Diseases, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:158-64. 2008
    ..To test the hypothesis that allelic variants of the paraoxonase-1 gene are associated with endothelial dysfunction, an early stage of atherosclerosis...
  12. ncbi request reprint Role of lipoprotein-associated phospholipase A2 in atherosclerosis
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Curr Atheroscler Rep 10:230-5. 2008
    ..In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA(2) has a pathophysiologic role in the atherosclerotic disease process. In this article, we review this aspect and its therapeutic implications...
  13. ncbi request reprint Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy
    Eugenia R Raichlin
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Heart Lung Transplant 26:826-33. 2007
    ..We investigated the role of insulin resistance and C-reactive protein (CRP) in predicting development of angiographic cardiac allograft vasculopathy (CAV)...
  14. ncbi request reprint Low-density lipoprotein particle size and coronary atherosclerosis in subjects belonging to hypertensive sibships
    Iftikhar J Kullo
    Divisions of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Am J Hypertens 17:845-51. 2004
    ..Whether LDL particle size is associated with the extent of coronary atherosclerosis in hypertensive sibships is unknown...
  15. ncbi request reprint Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
    Angela Dispenzieri
    Division of Hematology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Blood 104:1881-7. 2004
    ..Using this system, 49%, 38%, and 13% of patients were in stage I, stage II, and stage III, respectively. Determining levels of circulating biomarkers may be the most powerful tool for staging patients with AL undergoing PBSCT...
  16. ncbi request reprint Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress
    Offer Galili
    Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Physiol Heart Circ Physiol 292:H904-11. 2007
    ..Vascular dysfunction is therefore an early manifestation of obesity and might contribute to the increased cardiovascular risk, independently of insulin resistance...
  17. ncbi request reprint Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans
    Eric H Yang
    Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN 55905, USA
    Arterioscler Thromb Vasc Biol 26:106-11. 2006
    ..The purpose of the current study was to determine whether lipoprotein-associated phospholipase A2 (Lp-PLA2) is associated with coronary endothelial dysfunction and is a predictor of endothelial dysfunction in humans...
  18. ncbi request reprint Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis
    Ahmad A Elesber
    Division of Cardiovascular Disease, Nephrology, and Internal Medicine, Mayo College of Medicine, Rochester, MN 55905, USA
    Eur Heart J 27:824-31. 2006
    ....
  19. ncbi request reprint Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle-brachial index
    Simone Santos
    Divisions of Cardiovascular Disease, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Vasc Med 9:171-6. 2004
    ..The association of Lp-PLA2 with ABI merits further study...
  20. ncbi request reprint Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Mol Diagn Ther 11:219-26. 2007
    ..This review provides an overview of these studies, suggests plausible mechanisms for the association between endothelial dysfunction and Lp-PLA(2), and highlights future potential therapies...
  21. pmc Endurance exercise as a countermeasure for aging
    Ian R Lanza
    Division of Endocrinology, Endocrinology Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Diabetes 57:2933-42. 2008
    ..We determined whether reduced insulin sensitivity, mitochondrial dysfunction, and other age-related dysfunctions are inevitable consequences of aging or secondary to physical inactivity...
  22. ncbi request reprint Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease
    Jose S Pulido
    Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 82:301-7. 2007
    ..To determine whether either of the gene variants associated with age-related macular degeneration is associated with coronary artery disease (CAD)...
  23. ncbi request reprint Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships
    Iftikhar J Kullo
    Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Am J Hypertens 18:99-103. 2005
    ..We investigated heritability of these three lipid traits and the extent to which shared effects of genes (pleiotropy) contribute to the additive genetic variation in each trait in hypertensive sibships...
  24. pmc Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women
    Manivannan Srinivasan
    Division of Endocrinology, Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 94:761-4. 2009
    ..Very little evidence is available on the impact of DHEA administration on lipoprotein profile in women. DHEAS levels are very low/undetectable in hypoadrenal women...
  25. doi request reprint Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?
    Amir Lerman
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Am J Cardiol 101:11F-22F. 2008
    ..The purpose of this article is to review the evidence for the clinical utility of Lp-PLA(2), both as a risk marker and as a risk factor involved in the causal pathway of plaque inflammation and the formation of rupture-prone plaque...
  26. ncbi request reprint Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
    Emmanouil S Brilakis
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 26:137-44. 2005
    ..We aimed to evaluate the association of lipoprotein-associated phospholipase A2 (Lp-PLA2) with coronary artery disease (CAD) risk factors, with the severity of angiographic CAD, and with the incidence of major adverse events...
  27. doi request reprint Assessment of clinical performance without adequate analytical validation: A prescription for confusion
    Lawrence K Oliver
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Clin Biochem 44:1247-52. 2011
    ..Lp-PLA2 is a biomarker with promise for predicting cardiac risk. The lack of reproducible results has limited its use. In evaluating a new reagent kit, we investigated conditions for optimal reproducibility...
  28. ncbi request reprint C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal echocardiographic study
    Yoram Agmon
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Arch Intern Med 164:1781-7. 2004
    ..The purpose of this study was to examine the association of inflammatory markers with aortic atherosclerotic plaques in a sample of the general population and in a subgroup free of clinical vascular disease...
  29. pmc Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women
    Ada Igwebuike
    Division of Endocrinology, Endocrine Research Unit, Mayo Clinic, 200 First Street SW, Joseph 5 194, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 93:534-8. 2008
    ....
  30. ncbi request reprint Oxidative stress in obstructive sleep apnoea
    Anna Svatikova
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Eur Heart J 26:2435-9. 2005
    ..We tested the hypothesis that measures of oxidative stress are increased in otherwise healthy subjects with OSA when compared to closely matched OSA-free control subjects...
  31. ncbi request reprint Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk
    Virginia M Miller
    Departments of Surgery, Physiology and Biomedical Engineering, Mayo Clinic Rochester, Rochester, MN 55905, USA
    Curr Vasc Pharmacol 5:15-25. 2007
    ....
  32. ncbi request reprint Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community
    Yariv Gerber
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Arterioscler Thromb Vasc Biol 26:2517-22. 2006
    ..We evaluated the role of lipoprotein-associated phospholipase A2 (Lp-PLA2), an inflammatory biomarker, in defining risk after myocardial infarction (MI)...
  33. doi request reprint Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetry
    Nichole L Korpi-Steiner
    Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st Street S W, Rochester, MN 55905, United States
    Clin Chim Acta 400:33-6. 2009
    ..The present objective was to adapt CEM SmartTrac technology (i.e. (1)H NMR) to rapidly (< 5 min) quantitate fecal-fat and compare (1)H NMR and gravimetric performance characteristics...
  34. doi request reprint Aspirin responsiveness in healthy volunteers measured with multiple assay platforms
    Brad S Karon
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
    Clin Chem 54:1060-5. 2008
    ..We evaluated the sensitivity, precision, and concordance of 4 assays designed to detect aspirin responsiveness or resistance...
  35. ncbi request reprint Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins
    Angela Dispenzieri
    Division of Haematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Lancet 361:1787-9. 2003
    ..024 microg/L, less than 0.01 microg/L, and 0.084 microg/L, and for cTnI were 0.1 microg/L, 0.05 microg/L, and 0.24 microg/L, respectively. After multivariate analysis, cTnT proved a better predictor of survival than cTnI...
  36. ncbi request reprint Relation of C-reactive protein and fibrinogen to coronary artery calcium in subjects with systemic hypertension
    Iftikhar J Kullo
    Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Am J Cardiol 92:56-8. 2003
  37. ncbi request reprint C-reactive protein levels are influenced by common IL-1 gene variations
    Peter Berger
    Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cytokine 17:171-4. 2002
    ..These data indicate that IL-1 gene polymorphisms known to affect the inflammatory response are highly related to plasma levels of CRP and fibrinogen in patients referred for coronary angiography...
  38. ncbi request reprint Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid
    Emmanouil S Brilakis
    Division of Cardiovascular Diseases W16, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Atherosclerosis 165:375-81. 2002
    ..The homocysteine-lowering effect of folate-fortified flour, or the inclusion of many traditional and emerging risk factors in multivariate analysis, are potential explanations...
  39. ncbi request reprint Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation
    Chunsheng Liu
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA
    Circ Res 97:135-43. 2005
    ..This study has implications for interpretation of in vitro studies using CRP preparations containing azide at equivalent or higher concentrations...
  40. ncbi request reprint Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes
    Ananda Basu
    Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Endocr Pract 13:147-52. 2007
    ....
  41. ncbi request reprint Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method
    Linnea M Baudhuin
    Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Clin Biochem 37:481-8. 2004
    ..We investigated whether Lp(a) cholesterol measurement, which is not influenced by apo(a) size, is a viable alternative to measuring Lp(a) mass...
  42. ncbi request reprint Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests
    Gavin C Harewood
    Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:23-8. 2002
    ..All stool samples were subjected to blinded fecal occult blood determinations with use of the 3 tests...
  43. ncbi request reprint Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation
    Ali F Sonel
    Department of Cardiology, VA Pittsburgh Healthcare System and the University of Pittsburgh, Pittsburgh, Pennsylvania 15240, USA
    Pacing Clin Electrophysiol 30:839-44. 2007
    ..Implantable cardiac defibrillator (ICD) devices have been demonstrated to improve survival. It is not clear if ICDs would mitigate the negative outcome predicted by elevated troponin levels...
  44. ncbi request reprint Effect of myocardial ischemia on cardiac troponin I and T
    Raymond J Carlson
    Crouse Hospital, Syracuse, New York, USA
    Am J Cardiol 89:224-6. 2002
  45. pmc Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve
    Nalini M Rajamannan
    Division of Cardiology, Department of Medicine, Northwestern University Medical School, Chicago, Ill 60611, USA
    Circulation 105:2660-5. 2002
    ..We hypothesized that atherosclerosis and early bone matrix expression in the aortic valve occurs secondary to experimental hypercholesterolemia and that treatment with atorvastatin modifies this transformation...
  46. ncbi request reprint Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events
    Sotirios Tsimikas
    Division of Cardiovascular Diseases, University of California, San Diego, CA, USA
    J Lipid Res 48:425-33. 2007
    ..In conclusion, IgG and IgM OxLDL biomarkers have divergent associations with CAD in univariate analysis but are not independent predictors of CAD or clinical events...
  47. ncbi request reprint Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
    Sotirios Tsimikas
    Division of Cardiovascular Diseases, University of California, San Diego, La Jolla, CA 92093 0682, USA
    N Engl J Med 353:46-57. 2005
    ....
  48. ncbi request reprint Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults
    Richard B Lanman
    diaDexus, Inc, South San Francisco, CA 94080, USA
    Prev Cardiol 9:138-43. 2006
    ....
  49. doi request reprint Variability of lipoprotein-associated phospholipase A2 measurements
    Joseph P McConnell
    Clin Chem 54:932-3. 2008
  50. ncbi request reprint Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction
    Askiel Bruno
    Indiana University School of Medicine, Indianapolis, USA
    Stroke 35:727-30. 2004
    ..This pilot study was intended to evaluate the reproducibility of urinary 11-DTB2 over time and to look for evidence of aspirin resistance...
  51. ncbi request reprint Plasma thrombosis markers following cerebral infarction in African Americans
    Askiel Bruno
    Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 292, Indianapolis, IN 46202 5111, USA
    Thromb Res 115:73-7. 2005